DelveInsight’s “Alcoholic Hepatitis Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Alcoholic Hepatitis , historical and forecasted epidemiology as well as the Alcoholic Hepatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
DelveInsight has launched a new report on Alcoholic Hepatitis Disease Market Insights, Epidemiology and Market Forecast-2030
Alcoholic Hepatitis is a type of syndrome which occurs in patients with chronic and active heavy use of alcohol. This disease is most likely to affect the heavy drinkers and also in some cases it can affect the people who drink moderately. The most common sign of alcoholic hepatitis is jaundice, yellowing of skin, fatigue, weakness, loss of appetite, abdominal tenderness, nausea, and vomiting. Additional signs and symptoms that occur with severe alcoholic hepatitis includes confusion and behavior changes due to a buildup of toxins normally broken down and eliminated by the liver, fluid accumulation in abdomen, kidney and liver failure.
The major risk factor for alcoholic hepatitis is the quantity of alcohol a person consumes. However, alcoholic hepatitis can occur among those who drink less and have other risk factors, such as obesity, gender, genetic factors, race and ethnicity. It is known that it is an inflammatory disease and also proinflammatory mediators, such as tumor necrosis factor (TNF) that plays a critical role in liver injury. However, the pathogenesis of alcoholic hepatitis is multifactorial.
But current evidence recommends that the damage is the end result of the complex interplay between ethanol metabolism, inflammation and innate immunity. Such metabolic pathways generate reactive oxygen species that are potent inducers of lipid peroxidation, which in turn, causes hepatocyte death by necrosis or apoptosis.
Request for sample page:- Alcoholic Hepatitis Sample Page Link
Alcoholic Hepatitis Epidemiology
The Alcoholic Hepatitis epidemiology division provides insights about historical and current Alcoholic Hepatitis patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Some of the Report Key facts:-
- The total cases of alcoholic hepatitis related hospitalization increased from 249,884 in 2002 to 326,403 in 2010, based on the analysis of National Inpatient Sample data.
- Literature review has also suggested that although AH is an acute condition, nearly 50% of patients with AH has established cirrhosis at the time of clinical presentation.
- Although patients drinking ≥ 30-50 g/d for more than 5-10 years are considered at risk for developing Alcoholic Liver Disease (ALD), the disease does not develop in everyone with this amount of alcohol consumption. About 90% to 100% of heavy drinkers have steatosis, 10% to 35% have AH, and 8% to 20% have alcoholic cirrhosis
Report Key Benefits
1. Alcoholic Hepatitis market report covers a descriptive overview and comprehensive insight of the Alcoholic Hepatitis epidemiology Alcoholic Hepatitis market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. Alcoholic Hepatitis market report provides insights on the current and emerging therapies.
3. Alcoholic Hepatitis market report offers a global historical and forecasted market covering drug outreach in 7 MM.
4. Alcoholic Hepatitis market report provides an edge that will help in developing business strategies by understanding trends shaping and driving the Alcoholic Hepatitis market.
“According to the American Liver Foundation, about 10–50% of patients with alcoholic hepatitis have fulminant disease with high mortality rate and another 5–10% develop a prolonged illness which leads to death”
Some of the key companies working on alcoholic hepatitis that are given below-
- Afimmune Pharmaceutical Company
- Durect Pharmaceutical Corporation
Name of covered Drugs are given below.
1. Key Insights
2. Executive Summary of Alcoholic Hepatitis
3. Competitive Intelligence Analysis for Alcoholic Hepatitis
4. Alcoholic Hepatitis: Market Overview at a Glance
5. Alcoholic Hepatitis : Disease Background and Overview
6. Patient Journey
7. Alcoholic Hepatitis Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Alcoholic Hepatitis Treatment
11. Marketed Products
13. Alcoholic Hepatitis : Seven Major Market Analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Alcoholic Hepatitis
17. KOL Views
18. Market Drivers
19. Market Barriers
20.2. Report Methodology
21. DelveInsight Capabilities
23. About DelveInsight
Why should you buy this Alcoholic Hepatitis Report ?
- The report will help in developing business strategies by understanding trends shaping and driving the Alcoholic Hepatitis market
- To understand the future market competition in the Alcoholic Hepatitis market and Insightful review of the key market drivers and barriers
- Organize sales and marketing efforts by identifying the best opportunities for Alcoholic Hepatitis in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
- Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
- Organize sales and marketing efforts by identifying the best opportunities for Alcoholic Hepatitis market
- To understand the future market competition in the Alcoholic Hepatitis market
Alcoholic Hepatitis Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Alcoholic Hepatitis market.
DelveInsight’s Alcoholic Hepatitis – Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Alcoholic Hepatitis in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NEVADA 89107
Country: United States